ENERGY EFFICIENT NEUROMODULATION

• US 20140214129A1
• Filed: 01/24/2014
• Published: 07/31/2014
• Est. Priority Date: 01/28/2013
• Status: Abandoned Application

• Current Assignee: ReShape LifeSciences, Inc.
• Original Assignee: EnteroMedics, Inc. (ReShape LifeSciences, Inc.)
• Inventors: Waataja, Jonathan J., Donders, Adrianus P.
• Application Number:
  US14/163,503
• Publication Number:
  US 20140214129A1
• Time in Patent Office: Days
• US Class Current: 607/59
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/3605 Implantable neurostimulators for stimulating central or peripheral nerve system
• CPC Class Codes: A61N 1/37247 User interfaces, e.g. input or presentation means

Abstract

A therapy system for applying an electrical signal to a target nerve includes an electrode, an implantable component and an external component. The electrode has an impedance of at least about 2000 ohms. The electrical signal is applied using constant current or constant voltage.

Claims

1. A system for applying therapy to a target nerve of a subject comprising:

at least two electrodes, each having an impedance of at least 2000 ohms configured to be implanted within a body of the subject and placed at the target nerve,

an implantable component for placement in the body of the subject, the implantable component being configured to generate an electrical signal at a selected voltage or a selected current, wherein the electrical signal is selected to modulate activity on the target nerve, the implantable component being coupled to an implanted antenna;

an external component including an external antenna configured to be placed above the skin layer and adapted to communicate with the implanted antenna communication.

2. The system of claim 1, further comprising an external programmer configured to communicatively couple to the external component, the external programmer being configured to provide therapy instructions to the external component, wherein the external component is configured to send the therapy instructions to the implantable component via the external antenna and the implanted antenna.

3. The system of claim 2, wherein the external programmer includes a personal computer.

4. The system of claim 1, wherein the external component is adapted to be configured into a programming mode when the external programmer is coupled to the external component, wherein the external component does not provide power to the implantable component when configured in the programming mode.

5. The system of claim 1, wherein the electrode has an impedance of 10,000 to 10 megaOhms.

6. The system of claim 5, wherein the electrode is coated with an insulating material that has a resistivity of at least 10² ohm/cm.

7. The system of claim 6, wherein the electrode comprises a coating of acrylic paint, parylene, silicone rubber, polyurethane, polyether ether ketone, polyimide, polyethylene, Teflon, silica/quartz, iridium oxide, tantalum oxide, or aluminum oxide.

8. The system of claim 1, wherein the implantable component comprises circuitry to apply a constant voltage to the electrode.

9. The system of claim 8, wherein the selected voltage is about 20 volts or less.

10. The system of claim 1, wherein the frequency of the electrical signal is selected to downregulate nerve activity.

11. The system of claim 10, wherein the nerve is selected from the group consisting of vagus nerve, cranial nerves, celiac nerve, renal nerve, splanchnic nerve, the celiac plexus, and combinations thereof.

12. The system of claim 10, wherein the electrical signal has a frequency of at least 200 Hz.

13. The system of claim 1, wherein the electrical signal has a pulse width of at least 10 microseconds.

14. The system of claim 1, wherein the external component comprises a user interface that allow for selection of pulse widths.

15. The system of claim 1, wherein the external component comprises a user interface that provides for selection of a voltage.

16. The system of claim 1, wherein the frequency of the electrical signal is selected to upregulate activity on the target nerve.

17. The system of claim 16, wherein the target nerve is glossopharyngeal or baroreceptors.

18. The system of claim 16, wherein the frequency of the electrical signal is less than 200 Hz.

19. A method of treating a disorder in a subject comprising:

Applying at least two electrodes to a target nerve, wherein each electrode has an impedance of at least 2000 ohms and is operatively coupled to an implantable neuroregulator; and

Applying a therapy cycle to the target nerve, wherein the therapy cycle comprises applying an electrical signal at a selected voltage or selected current to the electrode intermittently, and wherein the electrical signal is selected to modulate activity on the target nerve.

20. The method of claim 19, wherein the disorder is selected from the group consisting of obesity, metabolic syndrome, diabetes, hypertension, inflammatory bowel disease, pancreatitis, and bulimia.

21. The method of claim 19, wherein the target nerve is a vagus nerve, a splanchnic nerve, a cranial nerve, celiac nerve, a glossopharyngeal nerve, a celiac nerve or a renal nerve.

22. The method of claim 19, wherein the electrode has an impedance of 10,000 to 10 megaOhms.

23. The method of claim 22, wherein the electrode is coated with an insulating material that has a resistivity of at least 10² ohm/cm.

24. The method of claim 23, wherein the electrode comprises a coating of acrylic paint, paralyene, silicone rubber, polyurethane, polyethylene, polyether ether ketone, polyimide, Teflon, silica/quartz, iridium oxide, tantalum oxide, aluminum oxide, or combinations thereof.

25. The method of claim 19, wherein the electrical signal has a frequency of at least 200 Hz.

26. The method of claim 19, wherein the electrical signal has a pulse width of at least 10 microseconds.

27. The method of claim 19, wherein the frequency of the electrical signal is selected to upregulate activity on the target nerve.

28. The method of claim 27, wherein the target nerve is glossopharyngeal or baroreceptors.

29. The method of claim 27, wherein the frequency of the electrical signal is less than 200 Hz.

30. A system for applying therapy to a target nerve of a subject comprising:

at least two electrodes, each having an impedance of at least 2000 ohms configured to be implanted within a body of the subject and placed at the target nerve, an implantable component for placement in the body of the subject, the implantable component being configured to generate an electrical filed, wherein the electrical field is selected to modulate activity on the target nerve, the implantable component being coupled to an implanted antenna;

an external component including an external antenna configured to be placed above the skin layer and adapted to communicate with the implanted antenna across the skin layer through radiofrequency communication.